C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2006
11/02/2006	WO2006114193A1 Peptides having an ace inhibiting effect
11/02/2006	WO2006114192A1 Peptides having an ace inhibiting effect
11/02/2006	WO2006114096A1 Pyrrolidinone dipeptide analogs and use thereof as artificial sweeteners
11/02/2006	US20060247157 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides
11/02/2006	US20060246104 Stable rgd peptidomimetic composition
11/02/2006	EP1717249A1 Peptides containing a cholesterol recognition sequence and their uses
11/02/2006	EP1716861A2 Inhibitors of proteasomal activity for stimulating bone and hair growth
11/02/2006	EP1715882A2 Smac peptidomimetics and the uses thereof
11/02/2006	EP1554237A4 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1155032B1 Process for the preparation of an n- [n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester agglomerate
11/02/2006	EP1036063B1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
11/02/2006	CA2605931A1 Diagnostic and therapeutic agents
11/02/2006	CA2604967A1 Pyrimidine derivatives and their use as p2y12 receptor antagonists
11/02/2006	CA2604786A1 Single-chain antibody with cleavable linker
11/01/2006	CN1856504A Anti-infarction molecules
11/01/2006	CN1856502A Macrocyclic peptides active against the hepatitis c virus
11/01/2006	CN1856501A Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compou
11/01/2006	CN1853732A Matrix metalloproteinase inhibitors as target component in diagnose agent
11/01/2006	CN1853730A Modified cytokines for use in cancer therapy
10/2006
10/31/2006	US7129374 Catalytic antioxidants and methods of use
10/31/2006	US7129261 Cytotoxic agents
10/31/2006	US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006	US7129215 induce the differentiation of HL-60 promyelocytic leukemia cells in vitro, to potentiate the activity of cytotoxic agents both in vitro and in vivo, and to stimulate colony formation of all three lineages of hematopoietic progenitor cells in normal human peripheral blood
10/31/2006	US7129214 Therapy for drug resistant bacteria
10/31/2006	US7129213 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
10/31/2006	US7128923 Mixture with non-formaldehyde preservative; microbiocides; chemical resistance; drugs, medical equipment, cosmetics; antiaging, wrinkle resistance; skin disorders
10/26/2006	WO2006113942A2 Method of inhibiting cathepsin activity
10/26/2006	WO2006058539A3 Growth hormone secretagogue receptor 1a ligands
10/26/2006	WO2006003330A3 Collections of traceable compounds and uses thereof
10/26/2006	US20060242719 Nucleotide sequences of shrimp beta-actin and actin promoters and their use in gentic transformation technology
10/26/2006	US20060241132 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/26/2006	US20060241057 provides compositions for inhibiting proteases, methods for synthesizing the compositions, and methods of using the disclosed protease inhibitors. Aspects of the disclosure include peptidyl allyl sulfone compositions that inhibit proteases, for example cysteine proteases, either in vivo or in vitro.
10/26/2006	US20060241056 Such as N-carbobenzyloxy-phenylalanyl-phenylalanylal; for treating cancer, inflammation, and/or autoimmune diseases; suppresses endogenous antigenic peptide generation
10/26/2006	US20060241055 Peptides promoting cell adherence, growth and secretion
10/26/2006	US20060241053 Compounds and their analgesic applications
10/26/2006	US20060241034 Means for preventing and treating cellular death and their biological applications
10/26/2006	US20060240562 Cleavable surfactants and methods of use thereof
10/26/2006	US20060239952 Cleaning composition and method for preparing the same
10/26/2006	US20060239923 Gastrin releasing peptide compounds
10/25/2006	EP1714974A2 HIV-1-and HIV-2-peptides for inhibition of membranes fusion-associated events, including HIV transmission
10/25/2006	EP1714973A1 Substances k01-0509 and process for producing the same
10/25/2006	EP1713823A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713822A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713771A1 New crystalline form of perindopril
10/25/2006	EP1713723A2 Fullerene based amino acids
10/25/2006	EP1373187A4 Novel aspartame powders
10/25/2006	EP1265849B1 Compounds and methods to treat alzheimer's disease
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	EP1129112B1 Peptides containing a cholesterol recognition sequence and their uses
10/25/2006	CN1852920A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10/25/2006	CN1852919A Agonist polypeptide of receptor for ZOT and zonulin
10/25/2006	CN1850854A Method for extracting glutathione from glutathione fermented broth
10/25/2006	CN1281618C Novel depsipeptide compound
10/24/2006	US7125872 protease/thrombin inhibitors
10/24/2006	US7125848 Administering conotoxins
10/24/2006	US7125845 Aza-peptide macrocyclic hepatitis C serine protease inhibitors
10/24/2006	US7125842 Anti-fungal compounds and methods of use
10/24/2006	CA2300603C New compounds of the benzylaminodiacetamide family, formulations including them, preparation process and uses
10/24/2006	CA2273549C Diagnostic agents for pancreatic exocrine function
10/24/2006	CA2261848C Cell adhesion inhibitors
10/19/2006	WO2006108211A1 Fragments of von willebrand factor a-related protein
10/19/2006	US20060235220 Dipeptide nitriles
10/19/2006	US20060234942 Use of at least one $g(a)62 casein peptide with angiotensin i converting enzyme inhibiting activity for preparing medicines, food products and food complements
10/19/2006	US20060234306 Assay method
10/18/2006	EP1711515A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/18/2006	EP1711514A1 Method of removing transition metals from reaction solutions comprising transition metal byproducts
10/18/2006	EP1465917B1 Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production
10/18/2006	EP0979239B1 Prevention and treatment of hepatocellular cancer
10/18/2006	CN1280286C Process for the industrial synthesis of thiophenecarboxylicacid, and application thereof
10/17/2006	US7122627 Lactam inhibitors of Hepatitis C virus NS3 protease
10/17/2006	US7122626 Halogen-substitued thienyl compounds
10/17/2006	US7122622 Somatostatin analogue as peptide and chelating group covalently linked to N-terminal free amino group of peptide, wherein analogue carries 1-naphthylalanine or 3-benzothienylalanine residue in 3-position; diagnosis
10/17/2006	US7122570 Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)
10/17/2006	US7122524 Stimulating nerve growth, administering glycyl-L-phenylalanyl-L-prolineamide, N,N-diethyl-isoleucyl-phenylalanyl-L-proline ethylamide, N,N-diethyl-isoleucyl-isoleucyl-prolineamide; due to ischemic, traumatic or toxic origin
10/17/2006	US7122523 Methods for inhibiting tumor cell proliferation
10/17/2006	US7122521 Collagen mimics
10/17/2006	US7122519 Didemnin analogs and fragments and methods of making and using them
10/17/2006	US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006	US7122516 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
10/17/2006	US7122193 Comprising peptide analogues which have a half-life which is clearly superior to that of natural proteins or that of synthetic peptides which are or are not derived from these natural proteins
10/17/2006	US7122190 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells
10/12/2006	WO2006106528A1 Novel peptides useful for treatment of alopecia
10/12/2006	US20060229433 Modified antiviral peptides with increased activity and cell membrane affinity
10/12/2006	US20060229432 synthetic vaccine; HIV; multi-antigenic construct comprising carbohydrate antigens linked with polypeptides
10/12/2006	US20060229255 Identification of n-alkylglycine trimers for induction of apoptosis
10/12/2006	US20060229254 Compounds having prolyl oligopeptidase inhibitory activity
10/12/2006	US20060229253 Pentapeptide compounds and uses related thereto
10/12/2006	US20060229236 Cyclic tetrapeptide compound and use thereof
10/12/2006	US20060228296 Method of screening groups of radioactive molecules and applications thereof
10/12/2006	DE60209458T2 Verfahren zur Synthese von (2S,3aS,7aS)-1-(S)-Alanyl-octahydro-1H-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril Process for the synthesis of (2S, 3aS, 7aS) -1- (S) -alanyl-octahydro-1H-2-carboxylic acid derivatives and use in the synthesis of perindopril
10/11/2006	EP1709179A1 Transgenic plants with reduced level of saturated fatty acid and methods for making them
10/11/2006	EP1709066A1 Inclusion complexes of perindopril
10/11/2006	EP1509300B1 Production of crystalline materials by using high intensity ultrasound
10/11/2006	EP1430045B1 Pyrane derivatives as both ace- and nep-inhibitors
10/11/2006	CN1845934A Process for the manufacture of an enantiopure compound
10/11/2006	CN1845920A 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10/11/2006	CN1845733A Tgf-beta gene expression inhibitor
10/11/2006	CN1279053C Modulators for beta-amyloid peptide aggregation comprising D-amino acids
10/10/2006	US7119171 A fibronectin type III (Fn3) monobody polypeptide consisting of two to six beta -strand domains with a loop region linked between each beta-strand domain, and such polypeptide is capable of binding to a target molecule

1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 307